Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07670520 · ClinicalTrials.gov registry record · NA
Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
A NA study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 2,260
- Enrollment target
NCT07670520: Recruiting NA study, sponsored by Mayo Clinic.
NCT07670520 is a NA study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,260 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07670520, a NA study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,260 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for acute kidney injury survivors on patient-centered outcomes.
Primary Outcome
Hospital-free days is defined as the total number of days a patient is alive and out of the hospital within the specified time frame.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Acute Kidney Injury in Care Transitions (ACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,260 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT07670520 shows while recruiting
NCT07670520 is an interventional study that assigns participants to a tested intervention. Its 2,260 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT07670520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07670520 about?
NCT07670520 is a clinical study titled "Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial". The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for acute kidney injury survivors on patient-centered outcomes.
What is the current status of trial NCT07670520?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,260 participants. The study started on 2026-04-16. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07670520?
The interventions under investigation include: Usual Care (BEHAVIORAL), Acute Kidney Injury in Care Transitions (ACT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07670520?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07670520's enrollment target sits among peer trials
2,260 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI